194 related articles for article (PubMed ID: 25448562)
1. Sylysia 350/Eudragit S100 solid nanomatrix as a promising system for oral delivery of cyclosporine A.
Dai W; Guo Y; Zhang H; Wang X; Zhang Q
Int J Pharm; 2015 Jan; 478(2):718-25. PubMed ID: 25448562
[TBL] [Abstract][Full Text] [Related]
2. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat.
Wang XQ; Fan JM; Liu YO; Zhao B; Jia ZR; Zhang Q
Int J Pharm; 2011 Oct; 419(1-2):339-46. PubMed ID: 21843612
[TBL] [Abstract][Full Text] [Related]
4. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
5. A promising nanomatrix system of simvastatin for oral delivery: Evaluation in vitro and in vivo.
He S; Duan L; Li Y; Cui Z; Zhang X
Pak J Pharm Sci; 2020 Nov; 33(6):2489-2495. PubMed ID: 33867321
[TBL] [Abstract][Full Text] [Related]
6. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.
Dai J; Nagai T; Wang X; Zhang T; Meng M; Zhang Q
Int J Pharm; 2004 Aug; 280(1-2):229-40. PubMed ID: 15265562
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of cyclosporine A pH sensitive nanoparticles and oral pharmacokinetics in rats].
Dai JD; Wang XQ; Zhang T; Meng M; Zhang X; Lü WL; Zhang Q
Yao Xue Xue Bao; 2004 Dec; 39(12):1023-7. PubMed ID: 15813034
[TBL] [Abstract][Full Text] [Related]
8. Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid.
Wang XQ; Huang J; Dai JD; Zhang T; Lü WL; Zhang H; Zhang X; Wang JC; Zhang Q
Int J Pharm; 2006 Sep; 322(1-2):146-53. PubMed ID: 16787721
[TBL] [Abstract][Full Text] [Related]
9. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats].
Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM
Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of cyclosporine A self-nanoemulsifying systems from osmotic pump tablets: near zero-order release and pharmacokinetics in dogs.
Zhang X; Yi Y; Qi J; Lu Y; Tian Z; Xie Y; Yuan H; Wu W
Int J Pharm; 2013 Aug; 452(1-2):233-40. PubMed ID: 23688622
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.
Wang XQ; Dai JD; Chen Z; Zhang T; Xia GM; Nagai T; Zhang Q
J Control Release; 2004 Jul; 97(3):421-9. PubMed ID: 15212874
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
13. Improving Solubility and Oral Bioavailability of Febuxostat by Polymer-Coated Nanomatrix.
Yin YF; Guo Y; Song WD; Duan XC; Zheng XC; Zhong T; Zhang S; Yao X; Xu MQ; Zhang Q; Zhang X
AAPS PharmSciTech; 2018 Feb; 19(2):934-940. PubMed ID: 29079988
[TBL] [Abstract][Full Text] [Related]
14. Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats.
Wang XQ; Dai JD; Zhang H; Zhang X; Wang JC; Zhang Q
J Nanosci Nanotechnol; 2008 May; 8(5):2422-31. PubMed ID: 18572658
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine a-loaded UniORV®: Pharmacokinetic and safety characterization.
Iyama Y; Mineda M; Sei S; Hirasawa W; Matahira Y; Seto Y; Sato H; Onoue S
Int J Pharm; 2019 Oct; 570():118630. PubMed ID: 31425819
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
[TBL] [Abstract][Full Text] [Related]
17. Self-micellizing solid dispersion of cyclosporine A for pulmonary delivery: Physicochemical, pharmacokinetic and safety assessments.
Suzuki H; Ueno K; Mizumoto T; Seto Y; Sato H; Onoue S
Eur J Pharm Sci; 2017 Jan; 96():107-114. PubMed ID: 27634579
[TBL] [Abstract][Full Text] [Related]
18. Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient.
Hirunpanich V; Sato H
Eur J Pharm Biopharm; 2009 Oct; 73(2):247-52. PubMed ID: 19560537
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier.
Zhang Y; Li X; Zhou Y; Fan Y; Wang X; Huang Y; Liu Y
Mol Pharm; 2010 Aug; 7(4):1169-82. PubMed ID: 20540526
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
Wang Y; Han X; Wang J; Wang Y
Int J Pharm; 2016 May; 505(1-2):35-41. PubMed ID: 27034003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
